Cargando…
Mitochondrial DNA in Uremia and New Targets to Treat Myocardial Hypertrophy in the Cardiorenal Syndrome
[Figure: see text]
Autor principal: | Bayliss, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436808/ https://www.ncbi.nlm.nih.gov/pubmed/36061339 http://dx.doi.org/10.1016/j.jacbts.2022.06.005 |
Ejemplares similares
-
Cardiac Spinal Afferent Denervation Attenuates Renal Dysfunction in Rats With Cardiorenal Syndrome Type 2
por: Xia, Zhiqiu, et al.
Publicado: (2022) -
Neuregulin-1: A Tonic for Cardiorenal Syndrome? And All Else That Ails Us?
por: Geissler, Andrew K., et al.
Publicado: (2023) -
SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection
por: Herat, Lakshini Y., et al.
Publicado: (2020) -
Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease
por: Han, Wenhao, et al.
Publicado: (2022) -
Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells
por: Ahmetaj-Shala, Blerina, et al.
Publicado: (2020)